MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.phrs.2020.105357

Медицинская библиотека · Pharmacological research · 2020

Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.

Di Bartolomeo Martina, Stark Tibor, Maurel Oriana Maria, Iannotti Fabio Arturo, Kuchar Martin, Ruda-Kucerova Jana, Piscitelli Fabiana, Laudani Samuele, Pekarik Vladimir, Salomone Salvatore, Arosio Beatrice, Mechoulam Raphael, Maccarrone Mauro, Drago Filippo, Wotjak Carsten T, Di Marzo Vincenzo, Vismara Matteo, Dell'Osso Bernardo, D'Addario Claudio, Micale Vincenzo

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Perinatal exposure to Δ9-tetrahydrocannabinol (THC) affects brain development and might increase the incidence of psychopathology later in life, which seems to be related to a dysregulation of endocannabinoid and/or dopaminergic systems. We here evaluated the transcriptional regulation of the genes encoding for the cannabinoid CB1 receptor (Cnr1) and the dopamine D2 receptor (Drd2) in perinatal THC-(pTHC) exposed male rats, focusing on the role of DNA methylation analyzed by pyrosequencing. Simultaneously, the molecular and behavioral abnormalities at two different time points (i.e., neonatal age and adulthood) and the potential preventive effect of peripubertal treatment with cannabidiol, a non-euphoric component of Cannabis, were assessed. The DRD2 methylation was also evaluated in a cohort of subjects with schizophrenia. We observed an increase in both Cnr1 and Drd2 mRNA levels selectively in the prefrontal cortex of adult pTHC-exposed rats with a consistent reduction in DNA methylation at the Drd2 regulatory region, paralleled by social withdrawal and cognitive impairment which were reversed by cannabidiol treatment. These adult abnormalities were preceded at neonatal age by delayed appearance of neonatal reflexes, higher Drd2 mRNA and lower 2-arachidonoylglycerol (2-AG) brain levels, which persisted till adulthood. Alterations of the epigenetic mark for DRD2 were also found in subjects with schizophrenia. Overall, reported data add further evidence to the dopamine-cannabinoid interaction in terms of DRD2 and CNR1 dysregulation which could be implicated in the pathogenesis of schizophrenia spectrum disorders, suggesting that cannabidiol treatment may normalize pTHC-induced psychopathology by modulating the altered dopaminergic activity.

Для цитирования: Di Bartolomeo Martina, Stark Tibor, Maurel Oriana Maria, Iannotti Fabio Arturo, Kuchar Martin, Ruda-Kucerova Jana, Piscitelli Fabiana, Laudani Samuele, Pekarik Vladimir, Salomone Salvatore, Arosio Beatrice, Mechoulam Raphael, Maccarrone Mauro, Drago Filippo, Wotjak Carsten T, Di Marzo Vincenzo, Vismara Matteo, Dell'Osso Bernardo, D'Addario Claudio, Micale Vincenzo. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.. Pharmacological research. 2020. DOI: 10.1016/j.phrs.2020.105357.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.